Atossa Genetics is a healthcare company developing cellular and molecular diagnostic risk assessment products for breast cancer patients.
31 7% Last mo
5 years ago
Use Atossa Genetics's historical employee count to better understand their growth and spending over time.
Unlock with a Free Trial
Use Atossa Genetics's historical monthly uniques as a proxy for mindshare and web traction.
Use Atossa Genetics's historical Twitter followers and likes to better understand their social media traction over time.
Use Atossa Genetics's historical Linkedin followers to better understand their social media traction over time.
Use Atossa Genetics's mobile downloads and app ranks to evaluate the performance of their mobile apps.
Atossa Genetic’s Janet Rea Presenting On ”TRAP CAR-T and Related Cell Therapies” at Adoptive T- Cell Therapy Symposium In San Francisco Feb. 15th
Atossa Genetics: Wait And See
2 Stocks Taking Cues for This Year’s Bull Market
Atossa Genetics (NASDAQ:ATOS) Now Covered by Analysts at Maxim Group. The Target Price is $2.0
Atossa Genetics Receives Additional Sell Side Support & Coverage – Shares Surge